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Abstract
Dysfunction of alsin, particularly its putative Rab5 guanine-nucleotide-exchange factor activity, has
been linked to one form of juvenile onset recessive familial amyotrophic lateral sclerosis (ALS2).
Multiple lines of alsin knockout (ALS2-/-) mice have been generated to model this disease. However,
it remains elusive whether the Rab5-dependent endocytosis is altered in ALS2-/- neurons. To
directly examine the Rab5-mediated endosomal trafficking in ALS2-/- neurons, we introduced green
fluorescent protein (GFP)-tagged Rab5 into cultured hippocampal neurons to monitor the
morphology and motility of Rab5-associated early endosomes. Here we report that Rab5-mediated
endocytosis was severely altered in ALS2-/-neurons. Excessive accumulation of Rab5-positive
vesicles was observed in ALS2-/- neurons, which correlated with a significant reduction in endosomal
motility and augmentation in endosomal conversion to lysosomes. Consequently, a significant
increase in endosome/lysosome-dependent degradation of internalized glutamate receptors was
observed in ALS2-/- neurons. These phenotypes closely resembled the endosomal trafficking
abnormalities induced by a constitutively active form of Rab5 in wild-type neurons. Therefore, our
findings reveal a negatively regulatory mechanism of alsin in Rab5-mediated endosomal trafficking,
suggesting that enhanced endosomal degradation in ALS2-/- neurons may underlie the pathogenesis
of motor neuron degeneration in ALS2 and related motor neuron diseases.
Background
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenera-
tive disease caused by the selective degeneration of spinal
and corticospinal motor neurons, resulting in muscle
weakness and atrophy along with spastic paralysis [1,2].
One form of inherited juvenile-onset amyotrophic lateral
sclerosis (ALS2) is caused by loss of function mutations in
the ALS2 gene [3-6]. Elucidation of the function(s) of
alsin is essential in [7]understanding the pathogenic
mechanism of this type of motor neuron disease.
Alsin, encoded by the full-length ALS2 gene, contains
three putative guanine-nucleotide-exchange factor (GEF)
domains based on the sequence homology [4,6]. Previous
studies indicate that the carboxyl-terminal vacuolar pro-
tein sorting 9 (VPS9)-like domain in conjunction with the
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upstream membrane occupation and recognition nexus
(MORN) motifs specifically facilitates GDP/GTP exchange
in Rab5 family GTPases [8,9]. Almost all reported muta-
tions in the ALS2 gene result in the loss of the VPS9
domain [4,6,10-13], suggesting that the proposed Rab5
GEF activity of alsin plays a critical role in protecting
motor neurons from degeneration.
Rab5 is essential in regulating organelle tethering, fusion
and microtubule-dependent motility during endocytosis
[14]. Early endosomes are constantly generated in the cell
periphery and targeted to either the recycling or lysosome-
dependent degradation pathway. The endosomes bound
for the degradation route migrate to the cell center while
growing in size and eventually fuse with lysosomes
[15,16]. Deficiency in endosomal trafficking has been
reported in mouse models of Down's syndrome and
Huntington's disease [17,18]. Similarly, the dynamics of
endosomal transport and fusion appear to be compro-
mised in cells derived from ALS2 knockouts (ALS2-/-)
mice. ALS2-/- fibroblasts when treated with epithelium
growth factor (EGF) show a delay in EGF receptor-medi-
ated endocytosis, which is supported by a similar study on
neurons treated with brain derived growth factor (BDNF)
[19,20]. However, since alsin is an activator of Rac1
GTPase [9,21] and Rac1 is also involved in EGF-induced
endocytosis [22], it is not clear that the delayed endocytic
response in ALS2-/-cells is due to the dysfunction of Rab5
or Rac1-dependent pathway.
To directly explore the function of alsin in Rab5-depend-
ent endosomal trafficking in neurons, we used green fluo-
rescent protein (GFP)-tagged Rab5 as a tracer to monitor
the size, motility, and degradation of endosomes in cul-
tured neurons derived from ALS2-/- mice [23,24]. Since
Rab5-mediated endosomal trafficking is also involved in
sequestration of glutamate receptors during synaptic
transmission [25,26], we also investigated the role of alsin
in the turnover of internalized glutamate receptors. We
found that deficiency in alsin led to a significant accumu-
lation of enlarged Rab5-associated endosomes in neu-
rons, which was correlated with a dramatic decrease of
endosomal motility and may contribute to the increased
lysosome-dependent degradation of internalized gluta-
mate receptors in ALS2-/- neurons. Our findings reveal a
novel function of alsin in negatively regulating Rab5-
mediated endosomal trafficking and suggest that
increased degradation of internalized cargo proteins may
contribute to the pathogenesis of ALS2 and related motor
neuron diseases.
Methods
Animals
The generation of ALS2-/- mice was described previously
[23]. The mice were housed in a 12-hour light/dark cycle
and fed regular diet ad libitum. The experimental protocols
utilized in this paper are in accordance with guidelines of
the Institutional Animal Care and Use Committees of the
National Institute of Child Health and Human Develop-
ment.
Expression Constructs
The full-length mouse ALS2 cDNA clone was obtained by
a combination of 5' RACE PCR and screening of a mouse
brain cDNA library (Origene, Rockville, MD). The cDNA
was then subcloned into modified pRK5 expression vec-
tors [27], which were tagged at the N-terminus with
DsRed (mono), a red fluorescent protein (RFP), or EGFP
obtained from Invitrogen (Grand Island, NY).
Neuron Culture and Transfection
Primary hippocampal cultured neurons were derived
from postnatal day 0 pups as described previously [23].
One million dissociated neurons were plated onto each
well of 6-well plates (Becton Dickinson Labware, Bedford,
MA) or Delta T dishes (Bioptechs Inc. Butler, PA) pre-
coated with poly-D-lysine (PDL, Sigma, St Louis, MO).
For immunofluorescence analysis, 0.3 million dissociated
neurons were plated on cover slips (Glaswarenfabrik Karl
Hecht KG, Sondhein, Germany) pre-coated with PDL.
Cultures were maintained in Basal Medium Eagle (Sigma)
supplemented with B27, N2, penicillin/streptomycin and
L-glutamine (Invitrogen), and incubated in a humidified
environment at 37°C and 5% CO2. 70% of the media was
changed every 3 d. Hippocampal neurons were trans-
fected 10 d after culture (DIV10) using Effectene transfec-
tion reagent (Qiagen, Germany) according to
manufacturer instructions. Neurons were fixed with 4%
paraformaldehyde for 10–15 min 4 d after transfection
and stored at 4°C for immunocytochemical analysis.
Time-lapse Fluorescence Microscopy and Image Capture
Dissociated hippocampal neurons were cultured on PDL
and ECL-coated Delta T dishes and perfused with fresh
culture medium supplemented with 20 mM HEPES (pH
7.3) during time-lapse imaging. Fluorescence microscopy
and digital image acquisition were carried out using a
Nikon ECLIPSE TE200 inverted fluorescence microscope
equipped with a Nikon 60 × 1.2 numerical aperture water
immersion objective and a cooled CCD camera driven by
the DeltaVision Real-Time Restoration Imaging System
(Applied Precision, LLC). The GFP and RFP-tagged pro-
teins were excited at 488 nm and 535 nm, and emitted flu-
orescence was collected through a 525–30 and a 610–75
nm band pass emission filter, respectively. To minimize
cell phototoxicity, we used a computer-driven automatic
shutter to achieve minimum illumination. An image
series constituted 150 time points at 1 sec intervals, and
each recording lasted 5 min. The kymography of vesicle
movement was prepared using ImageJ (NIH, Bethesda,
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MD). For some experiments, post time-lapse recording,
the cells were fixed and processed for immunostaining
with an anti-MAP2 antibody (Sigma).
Analysis of Endosomal Transport
The movement of Rab5-positive particles was analyzed
with the SoftWoRx Image Analysis System software
(Applied Precision, LLC). The particle diameters were
measured using the Standard Two Point method, and the
total movement distance of one particle (diameter > 0.1
μm) for 150 frames was measured with the leapfrog
method. The total distance (μm) that a particle traveled
was divided by the duration of the movement (second) to
obtain the average speed. At least three independent fields
were assessed for every experiment. Data was collected
from at least three individual experiments.
Immunocytochemistry
Fixed hippocampal neurons were permeabilized with
0.1% Triton X-100 in PBS for 10 min, blocked with 10%
normal goat serum at room temperature for 1 hour, and
incubated with primary antibody at 4°C overnight. The
next day, cells were washed three times with PBS, incu-
bated with Alexa 488 or Alexa 568 conjugated secondary
antibody (Invitrogen) at room temperature for one hour,
and mounted with Pro-Long Gold anti-fade regent (Invit-
rogen) after washing three times with PBS.
Confocal Imaging
A Zeiss LSM510 META Axioplan2 Confocal Microscope
(Carl Zeiss, Germany) was used with constant settings of
laser power, detector gain, amplification gain, pinhole,
and offset. Images were scanned using either a 63 × 1.4 NA
oil objective or 100 × 1.4 NA oil objective lens. A zoom
factor of 2 was used to obtain maximum resolution in 100
× images. Some images were acquired in z-series stack
scans at 1 μm intervals from individual fields to determine
the protein-protein co-localization between Rab5 and
LAMP1.
Co-localization Analysis
As described previously [28], confocal images processed
for co-localization analysis were collected using a 100 ×
1.4 NA oil objective lens; zoom setting, 2.0; z-step, 1 μm;
and image size, 1042 × 1042 pixels. Excitation filters were
used at 488 nm and 535 nm, and emitted fluorescence
was collected through a 525–30 and a 610–75 nm band
pass emission filter, respectively. During image collection,
the gain and offset level were set so that the full range of
pixel intensities was used (0–255) with very little satura-
tion at either end of the intensity range. The numbers and
total area covered by co-localized pixels were obtained
from co-localized table efferent from each image.
Cell Surface Protein Internalization Assay
As described previously [29], cortical neurons after 21d in
culture were used for cell surface protein internalization
assay. Briefly, cells were labeled with EZ-Link Sulfo-NHS-
SS-Biotin (Pierce, Rockford, IL) for 2 min at 37°C. After
washing in Tris-buffered saline, neurons were incubated
in medium with or without 100 μM AMPA for 15 min.
Membrane protein trafficking was halted by rapid cooling
to 4°C. Biotinylated proteins remaining on the cell sur-
face were stripped of biotin by the non-permeant reducing
agent glutathione (150 mM glutathione, 150 mM NaCl,
pH 8.75). Glutathione was subsequently neutralized by
50 mM iodoacetamide in PBS with magnesium and cal-
cium. Cells were lysed in modified RIPA buffer (1% Triton
X-100, 0.5% SDS, 0.5% deoxycholic acid, 50 mM NaPO4,
150 mM NaCl, 2 mM EDTA, 50 mM NaF, 10 mM sodium
pyrophosphate, 1 mM sodium orthovanadate, and pro-
tein inhibitor cocktail). To examine the effect of endo-
somal degradation in internalized proteins, neuronal
cultures were pretreated with 100 μg/ml leupeptin
(Sigma) 1 hr prior to biotinylation and kept incubated
with leupeptin through the rest of the experiment. The
homogenates were centrifuged at 14, 000 × g for 15 min
at 4°C. 10% of the supernatant was saved as total protein
input and the remaining supernatant was incubated with
100 μl of 50% UltraLink Immobilized NeutrAvidin agar-
ose beads (Pierce) for 3 hr at 4°C. The beads were washed
five times with RIPA buffer, and then bound proteins were
eluted with SDS sample buffer by boiling for 10 min.
Total protein and isolated biotinylated proteins were ana-
lyzed by immunoblotting with anti-GluR2, GluR2/3,
GluR1, NR1, ALS2, and β-tubulin antibodies. Protein
bands were visualized by ECL (Pierce) and quantified by
the Scion Image System (Scion, Frederick, MD).
Data Analysis
Because it is not certain that data are normally distributed,
the non-parametric Mann-Whitney test (SAS Institute
Inc., Cary, NC) was used to compare the two groups and
a p value of 0.05 was used as the criterion for significance.
Results
Accumulation of enlarged Rab5-associated endosomes in 
ALS2-/- hippocampal neurons
To investigate whether alsin-deficiency affects the mor-
phology of early endosomes, we expressed GFP-Rab5 in
hippocampal neurons derived from wild-type and ALS2-/-
mice. In wild-type neurons, a ubiquitous distribution of
GFP-Rab5-associated vesicles was observed in soma (Fig-
ure 1Aa, inset), axons (Figure 1Aa and 1Ac, middle panel),
and dendrites (Figure 1Aa and 1Ac, bottom panel), with
approximately 80% of GFP-Rab5-positive vesicles smaller
than 0.6 μm in diameter (average diameter = 0.5 ± 0.05
μm, Figure 1C–D) [24]. In contrast, significantly enlarged
GFP-Rab5-positive vesicles (average diameter = 0.9 ± 0.07
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Increased accumulation of enlarged Rab5-associated endosomes in ALS2-/- hippocampal neuronsFigure 1
Increased accumulation of enlarged Rab5-associated endosomes in ALS2-/- hippocampal neurons. A-B. Represent-
ative images of wild-type (WT; A) and ALS2-/- (KO; B) hippocampal neurons transfected with GFP-Rab5 (a, green) and counter-
stained with an antibody against MAP2 (b, red). Fragments of soma (inset), axon (middle panel) and dendrite (bottom panel) 
were enlarged to reveal the distribution and morphology of Rab5-positive vesicles. Panel 'c' is an overlay. Scale bar: 20 μm 
(main) and 5 μm (inset, middle and bottom panels). C. Histogram reveals the distribution of Rab5-associated vesicles within 
each size category in WT and KO neurons (n = 5). D. Histogram reveals the average size of Rab5-associated vesicles (n > 45) 
in wild-type (WT (Rab5)), ALS2-/- (KO (Rab5)), ALS2-transfected ALS2-/- (KO (Rab5+ALS2)) and DsRed-transfecetd ALS2-/- (KO 
(Rab5+vector)) neurons. Error bars represent SEM. *** P < 0.001.
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μm, p < 0.001, Fig. 1C and 1D) were observed in soma
(Figure 1Ba, inset), axons (Figure 1Ba and 1Bc, middle
panel), and dendrites (Figure 1Ba and 1Bc, bottom panel)
of ALS2-/- neurons. Except for the morphological changes
of Rab5-positive vesicles, ALS2-/- neurons appeared
healthy and maintained normal structures of nuclei, den-
drites and axons (Figure 1Bb). Furthermore, reintroduc-
tion of full-length ALS2 or VPS9 domain expression
construct, but not a control vector, into ALS2-/- neurons
significantly reduced the number of enlarged GFP-Rab5-
positive vesicles to a level comparable to wild-type neu-
rons (Figure 1D).
To test whether the increased accumulation of enlarged
Rab5-associated endosomes in ALS2-/- neurons was
dependent on Rab5 activities, we transfected GFP-Rab5A-
S34N (GFP-Rab5S), a dominant-negative mutant of Rab5
[30], into wild-type and ALS2-/- neurons (Figure 2A–B).
The size of GFP-labeled endosomes in ALS2-/-neurons
(Figure 2B) was similar to wild-type neurons (Figure 2A)
after introduction of GFP-Rab5S, suggesting that the
enlargement of Rab5-associated endosomes in ALS2-/-
neurons is resulted from Rab5-mediated endosome
fusion. As a control, over-expression of a constitutive
active form of Rab5, Rab5A-Q79L (Rab5Q), led to the
enlargement of Rab5-positive endosomes in both wild-
type and ALS2-/- neurons (Figure 2C–D).
Decreased motility of Rab5-positive endosomes in ALS2-/- 
hippocampal neurons
Rab5 is also involved in microtubule-based endosomal
transport [31]. To examine whether the transport of Rab5-
positive endosomes is impaired in ALS2-/- hippocampal
neurons, we measured the motility of Rab5-positive endo-
somes by time-lapse fluorescence imaging in neurons
transfected with GFP-Rab5 (Figure 3 and see Additional
files). As shown in the kymographs that summarized the
spatial position (x-axis) of each Rab5 vesicle over time (y-
axis), Rab5-positive endosomes moved in a rapid (average
speed = 0.29 ± 0.04 μm/sec), frequent, and asynchronous
manner in either anterograde or retrograde direction in
dendrites of wild-type neurons (Figure 3A, F and see Addi-
tional file 1). In contrast, the movement of GFP-Rab5-
positive vesicles in ALS2-/-neurons was significantly
slower (Figure 3B and 3F, average speed = 0.04 ± 0.005
μm/sec, p < 0.001) than that of wild-type controls. In fact,
most of the large Rab5-positive endosomes in ALS2-/- neu-
rons (diameter > 1 μm) were stationary (Figure 3B and see
Additional file 2). A similar reduced motility of Rab5-pos-
itive endosomes was also observed in wild-type neurons
transfected with Rab5Q (Figure 3C, F and see Additional
file 3), indicating that the slower movement of endo-
somes in ALS2-/- neurons may be caused by an increased
endosomal fusion. Reintroduction of ALS2 significantly
increased the motility of Rab5-positive vesicles in ALS2-/-
neurons (Figure 3D, F and see Additional file 4), while co-
transfection of a control vector (DsRed-vector) with GFP-
Rab5 had no such effect (Figure 3E, F and see Additional
file 5). Taken together, our data demonstrate that loss of
alsin severely disrupts Rab5-dependent endosomal traf-
ficking in neurons.
Increased co-localization of Rab5 and LAMP1 in large 
Rab5-associated endosomes of ALS2-/- hippocampal 
neurons
Many large Rab5-positive endosomes resulting from
fusion of early endosomes are subsequently targeted to
lysosomes for degradation and constitutive activation of
Rab5 enhances the conversion from endosomes to lyso-
somes [32]. To examine whether the large Rab5-associ-
ated endosomes in ALS2-/- hippocampal neurons are more
likely to be targeted to the late endosome and lysosome-
dependent degradation pathway, we stained GFP-Rab5
transfected ALS2-/- neurons with an antibody against lyso-
some membrane protein 1 (LAMP1), a marker for late
endosomes/lysosomes [33,34]. We found a substantial
increase of co-localization of Rab5 and LAMP1 immun-
ofluorescence signals in the soma of ALS2-/-neurons (Fig-
ure 4B–C), which reflects an enhanced conversion of early
endosomes to lysosomes for endosomal degradation. In
contrast, only very sparse co-localization of Rab5 and
LAMP1 staining was observed in wild-type neurons (Fig-
ure 4A and 4C, p < 0.05). Moreover, transfection of GFP-
Rab5Q induced a similar increase of co-localization of
LAMP1 and Rab5 in the soma of both wild-type and ALS2-
/- neurons (Figure 4D–E), indicating that increased Rab5-
mediated fusion of endosomes promotes the degradation
of early endosomes.
Increased Degradation of Internalized Glutamate 
Receptors in AMPA-Treated ALS2-/- Neurons
To investigate whether endocytosis of cell surface recep-
tors was altered in ALS2-/- neurons, we treated cultured
cortical neurons with AMPA, an analog of glutamate to
induce the internalization of glutamate receptors that
depends on the Rab5-mediated endosomal trafficking
pathway [25,26]. We first examined the AMPA-induced
internalization of glutamate receptors in ALS2-/- neurons.
Internalized proteins were labeled with biotin, which
were then affinity-purified and immunoblotted with anti-
bodies against glutamate receptors (Figure 5A–B). A sig-
nificant reduction of internalized receptors was observed
in AMPA-treated ALS2-/- neurons compared with AMPA-
treated wild-type controls (Figure 5A and 5C, p < 0.01). In
contrast, no significant alterations in internalized gluta-
mate receptor proteins were observed between mock-
treated wild-type and ALS2-/- neurons (Figure 5A). This
reduction of internalized glutamate receptors in ALS2-/-
neurons may result from either decreased endocytosis of
cell surface receptors or increased degradation of internal-
Molecular Brain 2009, 2:23 http://www.molecularbrain.com/content/2/1/23
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The Enlargement of Rab5-positive endosomes in ALS2-/- neurons may correlate with increased Rab5 activitiesFigure 2
The Enlargement of Rab5-positive endosomes in ALS2-/- neurons may correlate with increased Rab5 activities. 
Representative images of wild-type (WT) and ALS2-/- (KO) hippocampal neurons transfected with GFP-Rab5S (A and B) or 
GFP-Rab5Q (C and D). Fragments of soma (inset) were enlarged to reveal the distribution and morphology of Rab5-positive 
vesicles. Scale bar: 20 μm (main) and 5 μm (inset).
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ized proteins. To differentiate these two possibilities, prior
to AMPA application we treated neurons with leupeptin,
a specific lysosome inhibitor, to block lysosome-mediated
degradation of internalized glutamate receptors [35]. We
found no significant difference in internalized glutamate
receptors between wild-type and ALS2-/- neurons after
treatment with both leupeptin and AMPA (Figure 5B and
5D). Together, these data suggest that the endocytosis of
cell surface receptors might not be affected in ALS2-/- neu-
rons, while the lysosome-mediated degradation of gluta-
mate receptors is significantly enhanced in these neurons.
Discussion
Autosomal recessive mutations in the ALS2 gene lead to a
clinical spectrum of motor dysfunction including juvenile
onset amyotrophic lateral sclerosis (ALS2), primary lateral
sclerosis and hereditary spastic paraplegia [4,6,11]. Multi-
ple in vitro biochemical and cell biology assays suggest
that alsin dysfunction affects endosomal trafficking
through Rab5-mediated mechanism [8,9,19,20]. In this
report we extended those early studies and revealed some
novel functions of alsin in negatively regulating endo-
somal trafficking and degradation. We found that alsin-
deficiency led to increased endosomal fusion and degra-
dation, and decreased endosomal motility. Concomi-
tantly, we demonstrate that the degradation of
internalized AMPA receptors was significantly enhanced
in ALS2-/- neurons. Taken together, our data indicate that
excessive endosomal degradation in ALS2-/- neurons may
contribute to the pathogenesis of ALS2 and related motor
neuron diseases.
How alsin affects the Rab5-mediated endocytosis is a focal
point in understanding the function of alsin in motor
Decreased motility of Rab5-associated endosomes in ALS2-/- neuronsFigure 3
Decreased motility of Rab5-associated endosomes in ALS2-/- neurons. A-E. Representative kymographs of GFP-Rab5-
positive endosome movement in wild-type (WT (Rab5), A), ALS2-/- (KO (Rab5), B), Rab5Q-transfected wild-type (WT 
(Rab5Q), C), DsRed-ALS2 transfected ALS2-/- (KO (Rab5+ALS2), D), and DsRed-vector alone transfecetd ALS2-/- (KO 
(Rab5+vector), E) hippocampal neurons. Each kymograph summarizes the spatial positions (x-axis) of Rab5 endosomes at cer-
tain time points (y-axis) in one video field. F. Histogram shows the average speed of the Rab5-positive endosomes (n > 30) in 
WT (Rab5), KO (Rab5), WT (Rab5Q), KO (Rab5+ALS2), and KO (Rab5+vector) neurons. Error bars indicate SEM. **P < 0.05. 
***P < 0.01.
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Increased co-localization of LAMP1 with Rab5-associated vesicles in ALS2-/- neuronsFigure 4
Increased co-localization of LAMP1 with Rab5-associated vesicles in ALS2-/- neurons. (A-D) A lower (left) or higher 
magnification of Rab5-transfected wild-type (WT, A), or ALS2-/- (KO, B) neurons co-stained with LAMP1 (red) and GFP (green) 
antibodies. Co-localization of LAMP1 (red) and Rab5 (green) in WT and KO neurons was revealed by z-series stack images. 
Scale bars = 20 μm (left) and 10 μm (the rest) respectively. C. Quantitative analysis of co-localization of LAMP1 and Rab5 
immuno-reactivity in WT (n = 4) and KO (n = 7) neurons. Error bars indicate SEM. * P < 0.05. D-E. In the soma, LAMP1 (red) 
and Rab5Q (green) were co-localized in either GFP-Rab5Q-transfected wild-type (WT, D) or ALS2-/- (KO, E) neurons. Scale 
bar = 20 μm.
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neuron degeneration. To determine whether alsin acti-
vates Rab5 and promotes endosomal fusion, multiple
groups have transfected full-length alsin or truncated
forms containing either the VPS9 domain alone, or the
VPS9 domain with other domains. While all forms can
stimulate the release of bound GDP from Rab5 subfamily
GTPases in a cell free GDP dissociation assay, over-expres-
sion of full-length alsin is unable to stimulate Rab5-medi-
ated endosomal fusion as efficiently as truncated forms
lacking the chromosome condensation 1 (RCC1) like
domains (RLD) [8,9]. Analyses of a range of alsin deletion
constructs suggest that multiple domains influence its
Rab5-GEF activity [8]. While much of the current litera-
ture suggests that the DH/PH and VPS9 domains with
MORN motifs of alsin are necessary to promote Rab5
activity in the endocytic pathway, a regulatory role for the
RLD domain has been proposed [8]. Recently, two motor
neuron disease-related missense mutations (C156Y and
G540E) have been identified within the RLD domain,
indicating that this domain also plays an important role
in the normal function of alsin [36,37]. The RLD domain
consists of a seven-bladed propeller formed from internal
amino acid repeats [38]. When only the RLD domain of
alsin is expressed in cell lines, it displays a cytosolic distri-
bution similar to that of over-expression of full-length
alsin [8,9]. By contrast, over-expression of alsin lacking
Increased degradation of glutamate receptors in ALS2-/- neurons following AMPA treatmentFigure 5
Increased degradation of glutamate receptors in ALS2-/- neurons following AMPA treatment. A. The biotinylated 
internalized cell surface proteins were affinity purified and immunoblotted with antibodies against glutamate receptors: GluR1, 
GluR2, GluR2/3, and NR1 (labeled as "internalized"). The neurons were treated with mock (AMPA-) or AMPA (AMPA+) prior 
to the biotinylation. The expression of each glutamate receptor and β-tubulin in total cell lysate (labeled as "total") was also 
blotted to normalize the accumulation of internalized proteins. B. Similar to A, except that neurons were pre-incubated with 
lysosome inhibitor leupeptin. C. Histogram reveals a significant decrease of internalized glutamate receptors in KO neurons as 
compared with WT controls (n > 6). Error bars represent SEM. ** P < 0.01. D. Histogram shows that in the presence of leu-
peptin, no significant alteration of internalized glutamate receptors was observed between WT and KO neurons (n > 6). Error 
bars represent SEM.
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the RLD domain results in endosomal localization [8,39].
Therefore, the RLD domain of alsin may prevent the asso-
ciation of alsin with early endosomes and act as a negative
regulator of Rab5 mediated endosomal fusion. In line
with this notion, loss of alsin may expose more Rab5 to
the upstream activators and downstream effectors, and
enhance Rab5-mediated endosomal fusion, resulting in
an increased accumulation of enlarged endosomes as
observed in alsin-deficient neurons. Consistently, a recent
report revealed that the accumulation of enlarged insulin-
like growth factor 1 (IGF1) receptor-containing early
endosomes following IGF1 treatment is 1000 times
higher in ALS2-/- neurons compared to wild-type controls
[19]. The same report, however, also showed that the
cytosol prepared from ALS2-/- mouse brains dramatically
reduced its ability to promote Rab5-dependent early
endosomal fusion in a cell free assay, which is apparently
in conflict with its cell-based assays [19]. The different
observation in the cell-free assay [19] may reflect a deple-
tion of Rab5 downstream effectors in the cytosol of ALS2-
/- neurons due to an elevation of Rab5 activity.
Since we only disrupted the 2nd coding exon of ALS2 gene
in our knockout mice, an alternative explanation for the
observed abnormal aggregation of Rab5-positive vesicles
in ALS2-/- neurons is due to the presence of more active N-
terminal truncated form of alsin lacking the RLD domain.
However, this hypothesis is unlikely to be true, since no
short forms of alsin was detected in ALS2-/- mouse brain
lysates using an antibody specifically against the C-termi-
nal of alsin [23]. In addition, a recent study indicates that
ALS2CL, an alsin homologous protein [40], selectively
interacts with the VPS9 domain of alsin and prohibits the
enlargement of early endosoms induced by the N-termi-
nal truncated alsin [41]. Therefore, even if there is a trace
of N-terminal truncated alsin left in the ALS2-/- neuron, it
may not be capable to facilitate Rab5-depedent endsomal
fusion in the presence of ALS2CL.
Activation of Rab5 is also involved in endosomal trans-
port along the microtubule lattice [31]. Two previous
reports show that the internalization of epithelium
growth factor (EGF) and brain derived neuron growth fac-
tor (BDNF) receptors was slowed down in alsin-deficient
fibroblasts and neurons [19,20]. To further investigate the
role of alsin in endosomal transport, we traced the move-
ment of Rab5-positive vesicles by time lapse imaging in
ALS2-/- neurons. We found that the motility of Rab5-asso-
ciated endosomes was significantly decreased in ALS2-/-
neurons. Since disruption of microtubule-based endo-
somal transport causes the enlargement of Rab5-associ-
ated endosomes [31], it is possible that the accumulation
of enlarged Rab5-positive vesicles observed in ALS2-/- neu-
rons is due to the dysfunction of microtubule-based vesi-
cle transport. However, since a similar reduction of
endosomal motility was also observed in Rab5Q-trans-
fected wild-type neurons, our data argue that the
increased endosomal fusion may play a main role in caus-
ing the endosomal motility defects in ALS2-/- neurons. It is
of interest to determine the interplay between the endo-
somal fusion and transport. It also remains to determine
how alsin regulates Rab5-mediated endosomal transport.
Rab5 regulates both attachment and transport of early
endosomes along microtubules in a process dependent on
the activity of phosphatidylinositol-3-OH kinase, hVPS34
[31]. Since multiple domains of alsin, including the
MORN motifs, are predicted to bind phospholipids based
on sequence homology [4,6], it is possible that alsin acts
as a scaffold protein to assemble the protein complex,
which is important in endosomal transport.
Early endosomes targeted for the lysosome-dependent
degradation pathway keep growing in size while migrat-
ing to the cell center [16]. Consistently, we found exten-
sive co-localization of lysosome marker LAMP1 with
Rab5-positive vesicles in the soma of ALS2-/- neurons, sug-
gesting an increase of endosomal degradation. Since the
internalization and degradation of glutamate receptors
are both mediated by the Rab5-dependent endocytic
pathway [25,26], we quantified the internalization and
degradation of glutamate receptors ALS2-/-neurons. We
found an increased degradation of internalized glutamate
receptors in ALS2-/- neurons. Many studies have suggested
that down-regulation of calcium-impermeable GluR2-
containing AMPA type glutamate receptor complexes con-
tributes to motor neuron degeneration [42]. We have
reported previously that the cell/synaptic surface presenta-
tion of GluR2 is selectively decreased in ALS2-/- neurons
following AMPA treatment, which renders ALS2-/- neurons
more vulnerable to glutamate receptor-mediated toxic
stress [43]. The selective down-regulation of GluR2 at cell/
synaptic surface of ALS2-/- neurons may likely result from
the increased degradation of internalized GluR2 and the
deficiency in targeting the intracellular pool of GluR2 to
the plasma membrane.
Endosome dysfunction has emerged as a common patho-
genic pathway of many neurodegenerative diseases [44].
Neurons rely heavily on endocytosis to communicate
with each other or peripheral tissues for signal transduc-
tion and survival. The highly polarized structure of neu-
rons separates events during endocytosis at greater
distance, which may render neurons more vulnerable to
disturbance in the endocytic pathway. The transport of
endosomes and other organelles and their cargos into the
dendrites are essential to the pattern of dendritic branch-
ing and normal function of neurons [7,45]. Here, the
decreased motility of endosomes in ALS2-/- neurons may
very likely affect the transport of signaling endosomes that
carry signals for survival and differentiation of motor neu-
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rons. The increased degradation of internalized cargo pro-
teins, including neurotransmitter and neurotrophic
receptors may affect the synaptic transmission and intrac-
ellular signaling transduction in ALS2-/- neurons, which
may underlie the pathogenic mechanism of motor neuron
degeneration in ALS2 and related motor neuron diseases.
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